Clinical Research Directory

General Inclusion Criteria: Data from patients who sustained traumatic SCI, and who * completed at least one neurological examination in the acute / sub-acute stage of injury (between the day of injury and 40 days post-SCI) and in the chronic stage of injury (the latest neurological assessment between day 70 and day 546 after SCI) * agreed to provide their medical data for research purposes in the European Multicenter Study about Spinal Cord Injury (EMSCI) database specific for Cohort 1: MAP Cohort patients who * were initially admitted to the BG Trauma Center Murnau, or transferred for acute SCI care within two days after trauma * were treated in the intensive care unit (ICU) and underwent hemodynamic monitoring for at least 24 hours specific for Cohort 2: Biomarker Cohort - patients who had at least five blood samples collected within the first year after injury, with the first sample obtained within two weeks post-injury specific for Cohort 3: Opioid Cohort \- patients who were treated in the ICU and received opioid therapy, including detailed information on timing, dosage, and duration of administration Exclusion Criteria: * Patients with non-traumatic spinal cord injury or non-spinal cord injury * Patients who were initially admitted and/or surgically treated in another hospital and transferred to the BG Trauma Center Murnau later than two days post-SCI